Globally, Abbott has received reports of 736 severe adverse events linked to the issue, including seven deaths (none in the US)
Abbott is eyeing to become a global powerhouse in early cancer detection and precision oncology
The new formulation features what Abbott calls a “triple care system,” anchored by a blend of nutrients aimed at supporting blood sugar control and metabolic health
The company has posted net profit of Rs. 1,414.44 crores for the Financial Year ended March 31, 2025
Mistry is a seasoned finance professional having an extensive work experience spanning more than 25 years
Anushree has been with Abbott since 2021 and currently serving as Head of Strategy and Portfolio
Abbott's investigational Coronary Intravascular Lithotripsy (IVL) System offers a new potential treatment by using sound pressure waves to treat arterial calcium blockages
Prithwish has close to 28 years of experience in a Commercial role
The company has reported total income of Rs. 1,693.15 crores during the period ended September 30, 2024
This license will enable Abbott to enhance access to this novel therapy to more patients across India
Subscribe To Our Newsletter & Stay Updated
